Literature DB >> 7023954

B cell heterogeneity. II. Transplantation resistance in xid mice which affects the ontogeny of B cell subpopulations.

Z S Quan, R F Dick, B Regueiro, J Quintáns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023954     DOI: 10.1002/eji.1830110810

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  6 in total

1.  Immunoresponses to Neisseria meningitidis epitopes: primary versus secondary antiphosphorylcholine responses.

Authors:  J Faro; R Seoane; E Puentes; F Martínez Ubeira; B J Regueiro
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

2.  Effects of antigen and internal environment on anti-phosphorylcholine immune responses of autoimmune aged NZB/W F1 mice.

Authors:  R Seoane; J Faro; A Eiras; I Lareo; J Couceiro; B J Regueiro
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

3.  Rapid restoration of B-cell function in XID mice by intravenous transfer of peritoneal cavity B cells.

Authors:  L Prior; S Pierson; R T Woodland; J Riggs
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

4.  B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia.

Authors:  Hannah M Kerns; Byoung Y Ryu; Brigid V Stirling; Blythe D Sather; Alexander Astrakhan; Stephanie Humblet-Baron; Denny Liggitt; David J Rawlings
Journal:  Blood       Date:  2010-01-21       Impact factor: 22.113

5.  Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.

Authors:  R Pérez de Diego; E López-Granados; J Rivera; A Ferreira; G Fontán; J Bravo; M C García Rodríguez; S Bolland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

6.  Effect of clofibrate on the growth-kinetics of the murine P 1798(sc) lymphoma.

Authors:  F M Ubeira; R Seoane; E Puentes; J Faro; B J Regueiro
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.